PCM
Puissance Capital Management Portfolio holdings
AUM
$17.3M
This Quarter Return
+62.9%
1 Year Return
+149.36%
3 Year Return
+115.5%
5 Year Return
–
10 Year Return
–
AUM
$8.56M
AUM Growth
+$8.56M
(-79%)
Cap. Flow
-$170M
Cap. Flow
% of AUM
-1,982.61%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
–
Reduced
4
Closed
1
Top Buys
| 1 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
$126K |
Top Sells
| 1 |
BLPH
Bellerophon Therapeutics, Inc.
BLPH
|
$84.9M |
| 2 |
Ekso Bionics
EKSO
|
$55.9M |
| 3 |
VRAY
ViewRay, Inc.
VRAY
|
$28.9M |
| 4 |
TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
|
$99.2K |
| 5 |
SCYNEXIS
SCYX
|
$31.8K |
Sector Composition
| 1 | Healthcare | 29.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLPH
1
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $6.06M | 70.84% |
553,250
-7,745,505
| -93% | -$84.9M |
|
|
2
Ekso Bionics
EKSO
$10.3M
| $2.19M | 25.61% |
774,400
-19,760,498
| -96% | -$55.9M |
|
|
KDMN
3
DELISTED
Kadmon Holdings, Inc.
KDMN
| $126K | 1.47% |
+30,000
| New | +$126K |
|
4
Corvus Pharmaceuticals
CRVS
$422M
| $80K | 0.93% |
38,010
| – | – |
|
|
5
SCYNEXIS
SCYX
$35M
| $67K | 0.78% |
86,075
-40,790
| -32% | -$31.8K |
|
|
TCON
6
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $31K | 0.36% |
18,107
-57,941
| -76% | -$99.2K |
|
|
VRAY
7
DELISTED
ViewRay, Inc.
VRAY
| – | – |
-6,842,975
| Closed | -$28.9M |
|